StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > TAX loss selling season is here.

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Dec 01, 2020 7:15am

120 Views

Post# 32007577

RE:TAX loss selling season is here.

I don't see tax loss selling this year on this stock. Looking at the chart for the past 12 months doesn't show any real opportunities for that strategy. It was interesting to see Canaccord picking up almost 1 million shares yesterday.

StockscoutX wrote: It could create a buying opportunity for some at a good SP and then wait patiently for the next quarter release or news which could have an impact on SP.

As for most of the postings here. I wonder where are the adults?

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks